Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102.

MLA

Cusatis, Rachel, et al. “Health-Related Quality of Life in Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: BMT CTN 1102.” American Journal of Hematology, vol. 98, no. 2, Feb. 2023, pp. 229–50. EBSCOhost, https://doi.org/10.1002/ajh.26768.

APA

Cusatis, R., Martens, M. J., Nakamura, R., Cutler, C. S., Saber, W., Lee, S. J., Logan, B. R., Shaw, B. E., Gregory, A., D’Souza, A., Hamilton, B. K., Horowitz, M. M., & Flynn, K. E. (2023). Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102. American Journal of Hematology, 98(2), 229–250. https://doi.org/10.1002/ajh.26768

Chicago

Cusatis, Rachel, Michael J Martens, Ryotaro Nakamura, Corey S Cutler, Wael Saber, Stephanie J Lee, Brent R Logan, et al. 2023. “Health-Related Quality of Life in Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: BMT CTN 1102.” American Journal of Hematology 98 (2): 229–50. doi:10.1002/ajh.26768.